文献速递白血病造血干细胞移植与细胞治疗

循环CD1c+髓系树突状细胞是LCH病变CD1a+CD207+细胞的潜在前体

Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
PubMed 文献 · Blood Adv · 2020-01-01

朗格汉斯细胞组织细胞增生症(LCH)病变以CD1a+CD207+树突状细胞为特征,其起源尚不明确。本研究通过基因表达谱比较发现,LCH病变CD1a+CD207+细胞的转录组最富集CD1c+髓系树突状细胞(mDC)特征,且BRAFV600E等位基因存在于病变CD1c+ mDC中。HLA-DQB2在LCH病变CD1a+CD207+细胞中显著升高,并在BRAFV600E+患者外周血CD1c+细胞中富集,支持血CD1c+HLA-DQB2+ mDC迁移至病变处分化为致病性CD1a+CD207+细胞。

要点

  • LCH病变CD1a+CD207+细胞的转录组最富集CD1c+ mDC基因特征。
  • BRAFV600E等位基因存在于LCH病变的CD1c+ mDC中。
  • HLA-DQB2在LCH病变CD1a+CD207+细胞中显著升高,可作为潜在生物标志物。

核心结论

  • LCH病变CD1a+CD207+细胞可能来源于循环CD1c+HLA-DQB2+ mDC,后者携带激活的ERK迁移至病变处并分化。

研究设计与样本

  • 研究比较LCH病变CD1a+CD207+ DC与已知人髓系细胞亚群基因表达谱,并分析病变各髓系亚群及健康供者外周血CD1c+ mDC的转录组。

主要发现

  • LCH病变CD1a+CD207+ DC转录组最富集CD1c+ mDC基因特征。
  • BRAFV600E等位基因不仅见于CD1a+CD207-和CD1a+CD207+ DC,也见于病变CD1c+ mDC。
  • CD1a+CD207- DC转录组与CD1a+CD207+ DC几乎无法区分。
  • HLA-DQB2在LCH病变CD1a+CD207+ DC中较健康供者循环CD1c+ mDC显著升高。
  • HLA-DQB2抗原见于LCH病变CD1a+CD207-、CD1a+CD207+及CD1c+(CD1a+CD207-) mDC,不见于其他病变髓系亚群。

关键数值与推荐

  • HLA-DQB2表达特异性见于BRAFV600E+外周血单核细胞患者的外周血,且HLA-DQB2+CD1c+血细胞高度富集BRAFV600E。

临床怎么用

  • HLA-DQB2或可作为识别LCH循环前体细胞的潜在标志物,用于监测BRAFV600E+患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Langerhans cell histiocytosis (LCH) is a myeloproliferative disorder that is characterized by the inflammatory lesions with pathogenic CD1a+CD207+ dendritic cells (DCs). BRAFV600E and other somatic activating MAPK gene mutations have been identified in differentiating bone marrow and blood myeloid cells, but the origin of the LCH lesion CD1a+CD207+ DCs and mechanisms of lesion formation remain incompletely defined. To identify candidate LCH CD1a+CD207+ DC precursor populations, gene-expression profiles of LCH lesion CD1a+CD207+ DCs were first compared with established gene signatures from human myeloid cell subpopulations. Interestingly, the CD1c+ myeloid DC (mDC) gene signature was most enriched in the LCH CD1a+CD207+ DC transcriptome. Additionally, the BRAFV600E allele was not only localized to CD1a+CD207- DCs and CD1a+CD207+ DCs, but it was also identified in CD1c+ mDCs in LCH lesions. Transcriptomes of CD1a+CD207- DCs were nearly indistinguishable from CD1a+CD207+ DCs (both CD1a+CD207low and CD1a+CD207high subpopulations). Transcription profiles of LCH lesion CD1a+CD207+ DCs and peripheral blood CD1c+ mDCs from healthy donors were compared to identify potential LCH DC-specific biomarkers: HLA-DQB2 expression was significantly increased in LCH lesion CD1a+CD207+ DCs compared with circulating CD1c+ mDCs from healthy donors. HLA-DQB2 antigen was identified on LCH lesion CD1a+CD207- DCs and CD1a+CD207+ DCs as well as on CD1c+(CD1a+CD207-) mDCs, but it was not identified in any other lesion myeloid subpopulations. HLA-DQB2 expression was specific to peripheral blood of patients with BRAFV600E+ peripheral blood mononuclear cells, and HLA-DQB2+CD1c+ blood cells were highly enriched for the BRAFV600E in these patients. These data support a model in which blood CD1c+HLA-DQB2+ mDCs with activated ERK migrate to lesion sites where they differentiate into pathogenic CD1a+CD207+ DCs.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Lim KPH, Milne P, Poidinger M, et al. Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells. Blood Adv. 2020. PMID: 31899802. doi:10.1182/bloodadvances.2019000488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。